SI-BONE specializes in minimally invasive sacroiliac joint fusion surgery with its iFuse Implant System, which is designed to stabilize and fuse the sacroiliac joint. The company provides diagnostic services, treatment options, and patient support for SI joint dysfunction.

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

COM:SI-BONE

SI-BONE

Last Close

15.57

08/11 18:19

Market Cap

558.33M

Beta: -

Volume Today

108.47K

Avg: -

locale

market

industry

website

ipo date

competitor of

Metrics